Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycophorin E is a presumed pseudogene member of the glycophorin family located on chromosome 4 and closely related to Glycophorin A and B. While the gene is transcribed, the corresponding protein is generally not detected in red blood cells and is not considered functionally significant. GYPE is notable for its role in the evolution and structural diversity of the MNS blood group gene cluster. Rearrangements involving GYPE, GYPA, and GYPB generate hybrid alleles, which can result in rare blood group phenotypes and have implications for transfusion medicine. However, unlike its relatives Glycophorin A and B, Glycophorin E is not a functional membrane protein, receptor, or drug target in humans[1][3][2][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycophorin E (GYPE).